Blume Capital Management, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.

Quarter-by-quarter ownership
Blume Capital Management, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$137,511
+36.3%
1,350
+35.0%
0.04%
+36.7%
Q2 2023$100,910
+9.7%
1,0000.0%0.03%
+3.4%
Q1 2023$92,000
+407.1%
1,000
+400.0%
0.03%
+383.3%
Q4 2022$18,144
+21.0%
2000.0%0.01%0.0%
Q3 2022$15,000
-11.8%
2000.0%0.01%
-14.3%
Q2 2022$17,000
-5.6%
2000.0%0.01%
+16.7%
Q1 2022$18,000
-99.2%
200
-99.3%
0.01%
-99.2%
Q4 2021$2,376,000
+178.9%
27,158
+160.8%
0.78%
+151.3%
Q3 2021$852,000
-9.9%
10,413
+0.5%
0.31%
-9.8%
Q2 2021$946,000
+307.8%
10,363
+281.3%
0.35%
+280.2%
Q1 2021$232,000
+1121.1%
2,718
+1259.0%
0.09%
+1037.5%
Q4 2020$19,000
+11.8%
2000.0%0.01%
-11.1%
Q3 2020$17,0000.0%2000.0%0.01%0.0%
Q2 2020$17,000
+6.2%
2000.0%0.01%
-10.0%
Q1 2020$16,000
-11.1%
2000.0%0.01%
+11.1%
Q4 2019$18,000
+5.9%
2000.0%0.01%
+12.5%
Q3 2019$17,000
-5.6%
2000.0%0.01%
-11.1%
Q2 2019$18,000
-5.3%
2000.0%0.01%
-10.0%
Q1 2019$19,000
+11.8%
2000.0%0.01%0.0%
Q4 2018$17,0000.0%2000.0%0.01%
+11.1%
Q3 2018$17,000
+13.3%
2000.0%0.01%
+12.5%
Q2 2018$15,000
-6.2%
2000.0%0.01%
-11.1%
Q1 2018$16,000
-5.9%
2000.0%0.01%0.0%
Q4 2017$17,0000.0%2000.0%0.01%0.0%
Q3 2017$17,0000.0%2000.0%0.01%
-10.0%
Q2 2017$17,000
-59.5%
200
-64.9%
0.01%
-58.3%
Q1 2017$42,000
+2.4%
5690.0%0.02%
-4.0%
Q4 2016$41,000
-8.9%
5690.0%0.02%
-10.7%
Q3 2016$45,000
-4.3%
5690.0%0.03%
-9.7%
Q2 2016$47,000
+14.6%
5690.0%0.03%
+10.7%
Q1 2016$41,000
-58.2%
569
-50.0%
0.03%
-20.0%
Q4 2015$98,000
+88.5%
1,138
+100.0%
0.04%
-16.7%
Q3 2015$52,000
-7.1%
5690.0%0.04%0.0%
Q2 2015$56,000
-39.1%
569
-39.3%
0.04%
-34.4%
Q1 2015$92,000
+5.7%
9380.0%0.06%
+4.9%
Q4 2014$87,000
+148.6%
938
+154.2%
0.06%
+125.9%
Q3 2014$35,000
+6.1%
3690.0%0.03%
+3.8%
Q2 2014$33,000
+6.5%
3690.0%0.03%
+4.0%
Q1 2014$31,000
+3.3%
3690.0%0.02%0.0%
Q4 2013$30,0003690.02%
Other shareholders
NOVARTIS A G shareholders Q2 2015
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders